Qiagen NV (NYSE:QGEN)
$ 43.76 -0.39 (-0.88%) Market Cap: 9.73 Bil Enterprise Value: 10.24 Bil PE Ratio: 137.61 PB Ratio: 2.86 GF Score: 87/100

Qiagen NV at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Transcript

Feb 24, 2021 / 01:55PM GMT
Release Date Price: $53.01 (-3.78%)
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Okay. Great. Thank you for joining us. Excited to have Thierry Bernard, the CEO of QIAGEN with us for the next session here at the Citi conference.

I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. And Thierry, maybe I'll turn it over to you quickly just for a few minute intro, and then we'll dive into questions. If anyone has specific questions, I think there's an area on the screen to ask or feel free to e-mail me and I'll make sure to ask.

But Thierry, maybe I'll turn it over to you for a quick intro.

Thierry Bernard
QIAGEN N.V. - CEO

Okay. Thanks, Patrick, and very pleased to be with you guys. Good afternoon, good morning, depending on where you are in the world, but potentially good evening for some of you here in Asia as well. So in a few words, if you remember, when I was asked to take over at the end of 2019, we came to you to -- with some commitments of increased transparency and focusing on executing quarter after quarter.

I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot